Osteomed Smartflex Cranial Spring Distractor
Cranial Distraction System. 510(k) K123885, from Osteomed LP (Addison, TX). Product code PBJ, class 2.
As of Nov 17, 2026, K123885 is an FDA 510(k) held by Osteomed LP, substantially equivalent on Jun 3, 2013 after 167 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Jun 3, 2013
- Review time: 167 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe OsteoMed smartflex Cranial Spring Distraction System is intended for use in the treatment of cranial conditions such as syndromic craniosynostosis and congenital deficiencies in which osteotomies and gradual bone distraction are indicated. This device is intended to provide temporary stabilization and gradual lengthening of the cranial bones.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Osteomed Cranial Distraction SystemK121304 · Osteomed · Aug 22, 2012
- Molina Orbital Malar DistractorK003883 · KLS-Martin L.P. · Jan 23, 2001
- Osteomed External Mandibular Distraction SystemK063792 · Osteomed LP · Mar 2, 2007
- Osteomed Great Toe SystemK922211 · Osteomed Corp. · Nov 9, 1993
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- CranioXpandK230211 · KLS-Martin L.P. · Nov 21, 2023
Other PBJ Clearances
The newest 510(k)s for the same product code; see every PBJ device- CranioXpandK230211 · KLS-Martin L.P. · Nov 21, 2023
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 18, 2012
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5330
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files